| Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer CN Landen Jr, B Goodman, AA Katre, AD Steg, AM Nick, RL Stone, ... Molecular cancer therapeutics 9 (12), 3186-3199, 2010 | 464 | 2010 |
| Stem cell pathways contribute to clinical chemoresistance in ovarian cancer AD Steg, KS Bevis, AA Katre, A Ziebarth, ZC Dobbin, RD Alvarez, ... Clinical cancer research 18 (3), 869-881, 2012 | 404 | 2012 |
| Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer AD Steg, AA Katre, B Goodman, HD Han, AM Nick, RL Stone, ... Clinical cancer research 17 (17), 5674-5685, 2011 | 149 | 2011 |
| Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer ZC Dobbin, AA Katre, AD Steg, BK Erickson, MM Shah, RD Alvarez, ... Oncotarget 5 (18), 8750, 2014 | 143 | 2014 |
| Smoothened antagonists reverse taxane resistance in ovarian cancer AD Steg, AA Katre, KS Bevis, A Ziebarth, ZC Dobbin, MM Shah, ... Molecular cancer therapeutics 11 (7), 1587-1597, 2012 | 104 | 2012 |
| Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease RM Liu, T Van Groen, A Katre, D Cao, I Kadisha, C Ballinger, L Wang, ... Neurobiology of aging 32 (6), 1079-1089, 2011 | 98 | 2011 |
| Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer AJ Ziebarth, S Nowsheen, AD Steg, MM Shah, AA Katre, ZC Dobbin, ... Clinical cancer research 19 (1), 170-182, 2013 | 77 | 2013 |
| Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer RC Arend, AI Londoño-Joshi, A Gangrade, AA Katre, C Kurpad, Y Li, ... Oncotarget 7 (52), 86803, 2016 | 72 | 2016 |
| B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models BB Kasten, RC Arend, AA Katre, H Kim, J Fan, S Ferrone, KR Zinn, ... Nuclear medicine and biology 47, 23-30, 2017 | 63 | 2017 |
| Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma RC Arend, AI Londoño, AM Montgomery, HJ Smith, ZC Dobbin, AA Katre, ... Molecular Cancer Research 16 (5), 813-824, 2018 | 53 | 2018 |
| An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer MM Shah, ZC Dobbin, S Nowsheen, M Wielgos, AA Katre, RD Alvarez, ... Gynecologic oncology 134 (2), 331-337, 2014 | 53 | 2014 |
| Targeting RNA-polymerase I in both chemosensitive and chemoresistant populations in epithelial ovarian cancer R Cornelison, ZC Dobbin, AA Katre, DH Jeong, Y Zhang, D Chen, ... Clinical Cancer Research 23 (21), 6529-6540, 2017 | 52 | 2017 |
| Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer I Betella, WJ Turbitt, T Szul, B Wu, A Martinez, A Katre, JA Wall, L Norian, ... Gynecologic Oncology 157 (3), 765-774, 2020 | 50 | 2020 |
| Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth TB Turner, S Meza-Perez, A Londoño, A Katre, JE Peabody, HJ Smith, ... Oncotarget 8 (27), 44159, 2017 | 45 | 2017 |
| Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for Alzheimer's disease H Akhter, A Katre, L Li, X Liu, RM Liu Journal of Alzheimer's Disease 26 (4), 767-778, 2011 | 45 | 2011 |
| Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy JA Wall, S Meza-Perez, CB Scalise, A Katre, AI Londoño, WJ Turbitt, ... Gynecologic oncology 160 (1), 285-294, 2021 | 34 | 2021 |
| Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer AD Steg, MR Burke, HM Amm, AA Katre, ZC Dobbin, DH Jeong, ... Oncotarget 5 (16), 7065, 2014 | 34 | 2014 |
| Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer DW Doo, S Meza-Perez, AI Londoño, WN Goldsberry, AA Katre, ... Therapeutic advances in medical oncology 12, 1758835920913798, 2020 | 33 | 2020 |
| The antitumor effects of entinostat in ovarian cancer require adaptive immunity HJ Smith, TR McCaw, AI Londono, AA Katre, S Meza‐Perez, ES Yang, ... Cancer 124 (24), 4657-4666, 2018 | 31 | 2018 |
| Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice A Katre, C Ballinger, H Akhter, M Fanucchi, DK Kim, E Postlethwait, ... Inhalation toxicology 23 (8), 486-494, 2011 | 27 | 2011 |
